
Novomed Pharma Pvt. Ltd
About Novomed Pharma Pvt. Ltd
Data last updated:
Novomed Pharma Pvt. Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2007PTC173179. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mihir Prakash Shah and Binoy Baiju Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 114 Building No 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Novomed Pharma Pvt. Ltd's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address114 Building No 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Novomed Pharma Pvt. Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novomed Pharma is manufacturing. In detail, this covers food, beverages and tobacco products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C1 | Food, beverages and tobacco products |
To see the full business activity and turnover split of Novomed Pharma Pvt. Ltd, buy the company report.
Financials of Novomed Pharma Pvt. Ltd
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novomed Pharma Pvt. Ltd, buy the company report.
Board of directors of Novomed Pharma Pvt. Ltd
Novomed Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mihir Prakash Shah Also directs: Parnax Lab Limited, Naxpar Pharma Private Limited | Director | 01 Oct 2008 | 18 Years 1 Months | Current |
| Binoy Baiju Shah | Director | 30 Apr 2009 | 17 Years 6 Months | Current |
Auditor
Novomed Pharma Pvt. Ltd is audited by LADHA SINGHAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LADHA SINGHAL & ASSOCIATES | FY 2023 | 120241W |
Shareholding
The shareholding of Novomed Pharma Pvt. Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Novomed Pharma Pvt. Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Novomed Pharma Pvt. Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novomed Pharma Pvt. Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novomed Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Novomed Pharma Pvt. Ltd, buy the company report.
Recent activity
Novomed Pharma Pvt. Ltd has 5 board changes on record since 2008: 2 appointments and 3 cessations. The latest: Partho Sarthi Som ceased to be Director on 31 Mar 2012.
Frequently asked questions
Novomed Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 2007 (19+ years old) and is registered under CIN U24239MH2007PTC173179.
Novomed Pharma has 2 current directors:
- Mihir Prakash Shah - Director
- Binoy Baiju Shah - Director
The latest financial statements of Novomed Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Novomed Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Novomed Pharma is U24239MH2007PTC173179. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novomed Pharma was incorporated on 17 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Partho Sarthi Som ceased to be Director on 31 Mar 2012. Praveen Kumar ceased to be Director on 31 Mar 2012. Binoy Baiju Shah was appointed as Director on 30 Apr 2009. Novomed Pharma has 5 board changes on record in total.
The registered office of Novomed Pharma is at 114 Building No 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022.
Novomed Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Novomed Pharma is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.

